Brief: 4D Molecular Therapeutics Q1 net loss USD 28.682 million
10/05/2023 21:43
May 10 (Reuters) - 4D Molecular Therapeutics Q1 revenue USD 298 thousand. * Q1 net income USD -28.682 million * Q1 EPS USD -0.88
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings